Background: High serum uric acid (sUA) is an indicator of oxidative stress and is linked to tissue hypoxia in asthma. The objective of this case series was to investigate the prognostic role of sUA in patients with acute asthma exacerbations and the link between sUA and spirometric lung tests.
Introduction
Asthma is a longstanding inflammation affecting the airways of the lung, which is characterized by wheezing, difficulty breathing, and cough, in addition to the variable limitation of expiratory airflow.
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abdulnaby et al reactive oxygen species (ROS) formation is serum uric acid (sUA) formation and hence elevation in circulating urate. 4 Urate is a strong reducing substance and antioxidant, contributing to half of the plasma antioxidative capacity. sUA reacts with ROS and inhibits lipid peroxidation. 5 Thus, higher sUA levels could be a biomarker of oxidative stress. 6 Raised sUA levels are associated with tissue hypoxia due to degradation of adenosine. Increased levels of sUA with systemic inflammation were linked with high inflammatory markers (eg, C-reactive protein [CRP] and interleukin-6 ). Asthma leads to pulmonary hypoxia as well as elevated inflammatory signaling mediators, both of which elevate XOR expression. 7, 8 Thus, sUA also increases in other diseases such as gout and renal and cardiovascular diseases. 9, 10 Cigarette smoking can induce oxidative stress in addition to lung inflammation, even in healthy individuals. As a result of the extended duration of smoking exposure with subsequent inflammation and lung tissue disruption, pulmonary function is predominantly affected.
11
Aim of study
The objectives of the study were to investigate the possibility of sUA level to predict the severity of asthma in adolescents and adults during their acute asthma exacerbations and to identify if there is any link between sUA and pulmonary function tests during these acute exacerbations of asthma.
Patients and methods Patients
This study was conducted at the Chest Department, Pediatric Department, and Intensive Care Unit in Al Ansari Specialist Hospital in Yanbu Al-Sinaiyah, Saudi Arabia, during the period from November 2014 to December 2015. Yanbu Al-Sinaiyah is located in the coastal area of the Red Sea ~350 km northwest of Jeddah. This young city is a center for modern industries and contains gas separation factories. This study included 120 patients with acute asthma exacerbations (67 males and 53 females), with ages ranging from 13 to 56 years, and 120 healthy age-matched control participants (58 males and 62 females). The patients were further subdivided according to their age into two subgroups: 42 adolescents (#18 years) and 78 adults (.18 years).
Patients with asthma were diagnosed on the basis of medical history, symptoms and physical examination, according to the Global Initiative for Asthma 12 and the Saudi Initiative for Asthma. 13 The patients were first categorized according to their clinical assessment, arterial blood gases and measured peak expiratory flow rate percent of predicted (PEFR%) into mild, moderate, severe, and life-threatening asthma exacerbations. 13, 14 In mild asthma exacerbation, PEFR% was .75%; in moderate exacerbation, PEFR% was .50%-75%; in severe exacerbation, PEFR% was .33%-50% and in life-threatening asthma exacerbation, PEFR% was ,33%.
13,14 Then, they were finally classified into two subgroups: a moderate asthma subgroup, and severe and life-threatening asthma subgroup. Alansari Specialist Hospital Departments ethical committee approved this study. A written consent was taken from all participants or their guardians, if they were adolescents or unable to give written consent due to severe or life-threatening asthma.
The exclusion criteria included the following: 1. patients with mild asthma exacerbation; 2. patients with severe acute asthma exacerbation who were unable to do the spirometry test; 3. patients with family history of hyperuricemia and gout; 4. patients treated with xanthine derivatives (eg, theophylline) and diuretics; 5. patients associated with other lung diseases rather than asthma; 6. patients with other life-threatening diseases apart from acute asthma, such as stroke, coronary vascular disease, chronic renal failure, severe liver dysfunction, malignancies, acute gastrointestinal bleeding and advanced multiorgan disorders.
study design
The following investigations were carried out in this crosssectional observational study, and they were conducted on admissions of all asthma patients (adolescents and adults): Correlations between sUA and other variables were performed with two-tailed Pearson's correlation analysis.
Univariate regression analysis was first used to identify other potential significant independent variables such as age, BMI and smoking index that could affect sUA in patients with asthma. Only statistically significant variables (P,0.05) were entered into the multiple stepwise linear regression models to assess whether the severity of asthma still independently predicted high sUA, after correcting for these potential confounders. Owing to the strong association between spirometric and blood gas variables with sUA and severe asthma, two separate models were used to avoid their confounding effects. The following statistically significant clinical and demographic variables were entered into model 1: the sUA as a dependent variable and sex, smoking index, the severity of asthma, the number of asthma exacerbations and asthma duration as independent variables. In model 2, the statistically significant spirometric and blood gas variables were entered into the model as independent variables and sUA levels as a dependent variable.
The odds ratio (OR) of variables related to severe and life-threatening asthma was estimated by the binary logistic regression model. The Hosmer-Lemeshow (HL) test for logistic regression was used to answer the question, "How well does my model fit the data?". A non-significant P-value (.0.05) indicated a well-fitted model to the data.
Sensitivity, specificity and receiver operating characteristic (ROC) curve analyses were performed to evaluate sUA's predictive value of severity of asthma. A boxplot was used to describe the distribution of sUA, according to the severe asthma patient subgroup and the control subjects. For all tests, a significant level of statistics was considered when P,0.05.
Results
The characteristics of adolescent asthma patients and the control subjects are shown in Table 1 .
Significant statistical differences were found with regard to smoking index (P,0.03), and highly significant differences were observed in sUA, oxygen saturation, PO 2 , percent predicted forced vital capacity (FVC%), FEV 1 % and PEFR% (P,0.001). Similarly, comparison of adult asthma patients and their control subjects have shown the same significant differences (Table 2) .
Comparisons between moderate asthma patient subgroup and severe and life-threatening asthma patient subgroup are presented in Table 3 . The smoking index, asthma duration, the number of asthma exacerbations, ICU admission, treatment with MV, and hospitalization duration were all significantly higher among the patients with severe and life-threatening asthma (P,0.001). As expected, oxygen saturation, PaO 2 , FVC%, FEV 1 % and PEFR% were all significantly lower in the subgroup of patients with severe and life-threatening asthma than in the moderate asthma subgroup (P,0.001). It is also shown that sUA was statistically significantly higher in the severe and life-threatening, compared to the moderate, asthma subgroup, 6.7±0.76 vs 5.64±0.74, respectively (P,0.001).
A boxplot distribution of sUA (mg/dL) in asthmatic patient subgroups and healthy controls is illustrated in Figure 1 .
As shown in Table 4 , correlations were observed between sUA levels and relevant variables in asthmatic patients. Significant positive correlations were identified in the degree of asthma severity, the number of asthma exacerbations and smoking index with sUA (r-coefficients of 0.6, 0.42 and 0.29, 
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Predictive value of sUa in asthma excerbation To establish the likely predictors of high sUA in all asthma patients, first, a univariate regression analysis was done to identify separately the relevant risk factors predicting high sUA (Table 5) . Second, only significant risk factors (P,0.05) were entered into the multiple linear regression models. In model 1, the clinical and demographic variables were entered. It was observed that the degree of asthma severity, the number of asthma exacerbations and smoking index were significant predictive risk factors, explaining 43% of Table 6 Multiple linear regression for sUa-level predictors in the serum of asthmatic patients (n=120) the variability of sUA (R=0.65, R 2 =0.43, F=17.07, P,0.001). In model 2, the spirometric and blood gas variables were entered, and it was observed that oxygen saturation and PEFR% were significant predictive risk factors of high sUA (R=0.71, R 2 =0.50, F=22.88, P,0.001; Table 6 ). Figure 2 and Table 6 show the area under the ROC curve of 0.87 (95% confidence interval [CI] 0.81-0.94, P,0.001). Also used to reach the optimal cutoff point (with the maximal Figure 2 ROC curve for evaluating the prognostic performance of sUa in asthma severity in all age groups. Abbreviations: ROC, receiver operating characteristic; sUa, serum uric acid.
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abdulnaby et al sensitivity and specificity) of sUA levels associated with severity of asthma. The optimal cutoff point was 6.3 mg/dL, at which the sensitivity and specificity, with 95% CI, of sUA as a predictor of severity of asthma were 80% (70%-88%) and 90% (77%-97%), respectively (Table 7) .
Finally, binary logistic regression analysis was done to verify whether high sUA could be a risk factor for severe and life-threatening asthma. It was demonstrated that sUA, number of asthma exacerbations and asthma duration had ORs (95% CI) of 5.4 (2.5-8.6), 1.95 (1.5-5.7) and 1.3 (1.2-1.9) with P,0.001, P,0.002 and P,0.05, respectively. A wellfitted model was shown by a non-significant P-value by the HL test (P=0.48; Table 8 ).
Discussion
This study clarified the utility of sUA as a predictive marker in adolescents and adults with severe and life-threatening asthma exacerbations. Recently, a small number of studies 16, 17 have highlighted the link between asthma and sUA. Some interesting studies revealed alterations in the level of sUA in the asthma patient's airways and in experimental animals. 17, 18 Our study reports that patients generally with acute asthma exacerbations had a higher sUA as compared to healthy controls (P,0.001).Moreover, patients experiencing severe and life-threatening asthma had a higher sUA compared with patients with moderate asthma, 6.7±0.76 vs 5.6±0.74 (P,0.001). Our results were comparable to data from Li et al 19 and Sayyah. 20 The high sUA in patients with acute asthma exacerbations can be explained by the following: 1. The inflammation associated with cell apoptosis and necrosis will cause an increase in the metabolites of purine nucleotides (DNA and RNA) and will enhance the enzyme activity of xanthine oxidase with an increase in sUA concentration. 21, 22 2. Hypoxia leads to high adenosine triphosphate degradation (a purine nucleotide source) with an increased production of sUA by XO. [22] [23] [24] Many studies reported a frequent relationship between high sUA and inflammatory markers, particularly those induced by the recent acute inflammation. Therefore, it was not surprising to detect high sUA alongside elevated CRP, tumor necrosis factor-α and IL-6 in many inflammatory diseases. 7, [25] [26] [27] In the present study, significant positive correlations were demonstrated between sUA and number of asthma exacerbations (r=0.42) and cigarette smoking index (r=0.29). Conversely, significant negative correlations were demonstrated between oxygen saturation (r=-0.48), PaO 2 (r=-0.29), FVC% (r=-0.44), FEV 1 % predicted (r=-0.44), PEFR% (r=-0.66) and sUA levels. Li et al 19 similarly reported a significant association of sUA levels with impaired lung function. Furthermore, a Japanese study 27 revealed a considerable link between spirometric indices and sUA. The following proposed mechanisms may explain the negative correlations between sUA and spirometric parameters: first, tissue hypoxia during asthma exacerbation induces the production of sUA, and second, high levels of sUA may enhance lung inflammation, which eventually impairs pulmonary function. 27, 28 Finally, in the current study, the sensitivity and specificity of sUA as a predictive of the severity of asthma were found to be 80% and 90%, respectively, at the cutoff point of 6.3 mg/dL, and the zone beneath the curve was 0.87 (P,0.001). Furthermore, a binary logistic regression model for the calculation of an OR related to severe and life-threatening asthma showed that sUA, the number of asthma exacerbations, and asthma duration had an OR of 5.4 (P,0.001), 1.95 (P,0.002) and 1.3 (P,0.05), respectively. Therefore, it can be concluded that sUA may be used as a useful non-invasive prognostic indicator of the severity of asthma exacerbation.
In turn, the possibility of the presence of other covariates could affect the sUA level in patients with acute asthma exacerbations in the current study. The multiple linear regression model's clinical and demographic variables revealed 
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Predictive value of sUa in asthma excerbation that besides severe asthma, smoking and the number of asthma exacerbations are predictive of high sUA. In model 2, "spirometry and blood gas variables", low PEFR% and oxygen saturation were also predictive of high sUA. It is known that there are other factors that could affect sUA such as sex, BMI, cigarette smoking and chronic lung, kidney and cardiovascular diseases. [29] [30] [31] In contrast to the current study, a couple of studies 32, 33 reported a low sUA and other antioxidant compounds such as vitamin C and vitamin E in asthmatic patients. This contradiction may be explained partly by the following: 1. Various factors could affect the serum level of sUA, including cardiac and vascular diseases, type of food ingested, cigarette smoking, renal insufficiency and hereditary metabolic disorders of purine. 34 2. The differences in the patients studied, as one study was in adults and the other was in children with asthma. 28 3. The existence of an additional antioxidant deficiency such as vitamin D or vitamin C, which may be linked simultaneously to asthma severity. 32, 33, 35 4. sUA is one of the non-enzymatic antioxidants during an asthma exacerbation. It acts as a protective mechanism against the lung damage by large amounts of oxidants. Reduction of sUA could be an indicator of the reduced capability of the antioxidant defense system in patients with acute asthma exacerbations.
36-38
The present study was not without limitations, as other antioxidant deficiencies, for example, selenium and some vitamins were not evaluated in this study, which may coexist in asthmatic patients and may affect the severity of asthma. Thus, further large prospective studies are necessary to clarify the connection of sUA with the severity of asthma.
Conclusion
High sUA has a significant positive correlation with severe and life-threatening asthma and a negative correlation with spirometric pulmonary functions in adolescents and adults. It may be a predictive value of severity of asthma. However, other comorbid factors such as the number of asthma exacerbations, asthma duration and cigarette smoking have also been shown to affect the sUA level and should be considered.
In view of the results of this study, sUA may be considered as an accessible, useful and low-cost marker of the severity of asthma exacerbations.
